Optical Control of Insulin Secretion Using an Incretin Switch

Incretin mimetics are set to become a mainstay of type 2 diabetes treatment. By acting on the pancreas and brain, they potentiate insulin secretion and induce weight loss to preserve normoglycemia. Despite this, incretin therapy has been associated with off‐target effects, including nausea and gastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Broichhagen, Johannes, Podewin, Tom, Meyer‐Berg, Helena, von Ohlen, Yorrick, Johnston, Natalie R., Jones, Ben J., Bloom, Stephen R., Rutter, Guy A., Hoffmann‐Röder, Anja, Hodson, David J., Trauner, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY‐VCH Verlag 2015
Materias:
Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736448/
https://www.ncbi.nlm.nih.gov/pubmed/26585495
http://dx.doi.org/10.1002/anie.201506384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736448/
https://www.ncbi.nlm.nih.gov/pubmed/26585495
http://dx.doi.org/10.1002/anie.201506384

Ejemplares similares